UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 135

Sortiert nach

Aurora-A mediated phosphorylation of LDHB promotes glycolysis and tumor progression by relieving the substrate-inhibition effect

Nature communications, 2019-12, Vol.10 (1), p.5566-16, Article 5566

2019

Link zum Volltext

Verfügbarkeit prüfen

Assessment of ovarian cancer conditions from exhaled breath

International journal of cancer, 2015-03, Vol.136 (6), p.E614-E622

2015

Link zum Volltext

Verfügbarkeit prüfen

Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2021-01, Vol.13 (1), p.e1654-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma

Oncotarget, 2017-04, Vol.8 (16), p.26434-26447

2017

Link zum Volltext

Verfügbarkeit prüfen

Quantitative breath analysis of volatile organic compounds of lung cancer patients

Lung cancer (Amsterdam, Netherlands), 2010-02, Vol.67 (2), p.227-231

2010

Link zum Volltext

Verfügbarkeit prüfen

Differentiation between genetic mutations of breast cancer by breath volatolomics

Oncotarget, 2015-12, Vol.6 (42), p.44864-44876

2015

Link zum Volltext

Verfügbarkeit prüfen

The p53/miR-193a/EGFR feedback loop function as a driving force for non-small cell lung carcinoma tumorigenesis

Therapeutic advances in medical oncology, 2019-05, Vol.11, p.1758835919850665-1758835919850665

2019

Link zum Volltext

Verfügbarkeit prüfen

Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

Molecular medicine reports, 2014-08, Vol.10 (2), p.931-938

2014

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Significance Of Platelet-To-Lymphocyte Ratio (PLR) And Mean Platelet Volume (MPV) During Etoposide-Based First-Line Treatment In Small Cell Lung Cancer Patients

Cancer management and research, 2019-01, Vol.11, p.8965-8975

2019

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules

ACS nano, 2017-01, Vol.11 (1), p.112-125

2017

Link zum Volltext

Verfügbarkeit prüfen

The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Patients with Small Cell Lung Cancer Before First-Line Treatment with Etoposide and Progression-Free Survival

Medical science monitor, 2019-07, Vol.25, p.5630-5639

2019

Link zum Volltext

Verfügbarkeit prüfen

EPOR mRNA level: A valuable prognostic indicator for patients with ER+ breast cancer

Asian Pacific journal of tropical medicine, 2018-04, Vol.11 (4), p.297-304

2018

Link zum Volltext

Verfügbarkeit prüfen

Distinct fibroblast subpopulations associated with bone, brain or intrapulmonary metastasis in advanced non‐small‐cell lung cancer

Clinical and translational medicine, 2024-03, Vol.14 (3), p.e1605-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical Features and Short-Term Outcomes in COVID-19-Infected Patients with Cancer

Cancer management and research, 2020-01, Vol.12, p.12021-12028

2020

Link zum Volltext

Verfügbarkeit prüfen

A meaningful attempt: Applying dielectric barrier discharge plasma to induce apoptosis of MDA-MB-231 cells via regulating HIF-1α/VEGFA expression

Surface & coatings technology, 2020-11, Vol.401, p.126293, Article 126293

2020

Link zum Volltext

Verfügbarkeit prüfen

Peripheral blood lymphocyte/monocyte ratio predicts outcome for patients with diffuse large B cell lymphoma after standard first-line regimens

Annals of hematology, 2014-04, Vol.93 (4), p.617-626

2014

Link zum Volltext

Verfügbarkeit prüfen

Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma

BMC cancer, 2014-05, Vol.14 (1), p.341-341, Article 341

2014

Link zum Volltext

Verfügbarkeit prüfen

Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS study

Journal of cancer research and clinical oncology, 2023-09, Vol.149 (12), p.10771-10780

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical analysis of premedication regimen with dexamethasone at different doses for docetaxel-induced hypersensitivity reaction

Zhōnghuá zhŏngliú zázhì, 2009-10, Vol.31 (10), p.795

2009

Link zum Volltext

Verfügbarkeit prüfen

Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study

Breast cancer research and treatment, 2018-04, Vol.168 (2), p.389-399

2018

Link zum Volltext

Verfügbarkeit prüfen

Molecular mechanism underlying the anticancer effect of simvastatin on MDA-MB-231 human breast cancer cells

Molecular medicine reports, 2015-07, Vol.12 (1), p.623-630

2015

Link zum Volltext

Verfügbarkeit prüfen

The Screening of Volatile Markers for Hepatocellular Carcinoma

Cancer epidemiology, biomarkers & prevention, 2010-09, Vol.19 (9), p.2247-2253

2010

Link zum Volltext

Verfügbarkeit prüfen

The lower peripheral blood lymphocyte/monocyte ratio assessed during routine follow-up after standard first-line chemotherapy is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma

Leukemia research, 2014-03, Vol.38 (3), p.323-328

2014

Link zum Volltext

Verfügbarkeit prüfen

Association of IL-10-1082 promoter polymorphism with susceptibility to gastric cancer: evidence from 22 case–control studies

Molecular biology reports, 2012-06, Vol.39 (6), p.7143-7154

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(129)

Publikationsform

Artikel
(130)
Tagungsberichte
(5)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Aurora-A mediated phosphorylation of LDHB promotes glycolysis and tumor progression by relieving the substrate-inhibition effect

Assessment of ovarian cancer conditions from exhaled breath

Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy

Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial

RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma

Quantitative breath analysis of volatile organic compounds of lung cancer patients

Differentiation between genetic mutations of breast cancer by breath volatolomics

The p53/miR-193a/EGFR feedback loop function as a driving force for non-small cell lung carcinoma tumorigenesis

Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

Prognostic Significance Of Platelet-To-Lymphocyte Ratio (PLR) And Mean Platelet Volume (MPV) During Etoposide-Based First-Line Treatment In Small Cell Lung Cancer Patients

Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules

The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Patients with Small Cell Lung Cancer Before First-Line Treatment with Etoposide and Progression-Free Survival

EPOR mRNA level: A valuable prognostic indicator for patients with ER+ breast cancer

Distinct fibroblast subpopulations associated with bone, brain or intrapulmonary metastasis in advanced non‐small‐cell lung cancer

Clinical Features and Short-Term Outcomes in COVID-19-Infected Patients with Cancer

A meaningful attempt: Applying dielectric barrier discharge plasma to induce apoptosis of MDA-MB-231 cells via regulating HIF-1α/VEGFA expression

Peripheral blood lymphocyte/monocyte ratio predicts outcome for patients with diffuse large B cell lymphoma after standard first-line regimens

Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma

Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS study

Clinical analysis of premedication regimen with dexamethasone at different doses for docetaxel-induced hypersensitivity reaction

Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study

Molecular mechanism underlying the anticancer effect of simvastatin on MDA-MB-231 human breast cancer cells

The Screening of Volatile Markers for Hepatocellular Carcinoma

The lower peripheral blood lymphocyte/monocyte ratio assessed during routine follow-up after standard first-line chemotherapy is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma

Association of IL-10-1082 promoter polymorphism with susceptibility to gastric cancer: evidence from 22 case–control studies

Suchergebnisse filtern